APOE and epilepsy: The robust neuronal-glial response to the neuronal stress of epilepsy in APOE ε3,3 carriers suggests that overall they have an advantage over other genotypes as indicated by an ability to increase neuronal acute phase protein expression, a greater neuronal size, and increased resilience, as indicated by lower levels of markers for RNA and DNA damage, and lower susceptibility to inappropriate cell cycling and death pathways.